We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

DOD Slow To Target Rising Rx Costs, Fraud Risks: Watchdog

Law360, Nashville (November 20, 2017, 8:25 PM EST) -- The U.S. Department of Defense’s health care arm had been too slow to respond to risks of fraud posed by drugs with rapidly rising costs, only recently updating its rules to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.